Healthcare ❯ Pharmaceuticals

Biopharmaceuticals

Drug Development Clinical Trials Generic Drugs Clinical-stage Biopharmaceutical Companies Duchenne Muscular Dystrophy Corporate Acquisitions Insmed Teva Pharmaceutical Industries Limited Generic Medicines Oncology Respiratory Diseases Bristol-Myers Squibb Company

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

The strategy concentrates resources on oral GLP-1 launches, reflecting rising analyst confidence in orforglipron.

PGIM Jennison’s Q2 Letter Details Health-Care Slide, Portfolio Shifts and Company Catalysts

BMO Raises AbbVie Target to $240 After Rinvoq Generic Dispute Is Resolved

Teva Wins FDA Fast Track for Emrusolmin in Multiple System Atrophy

Biohaven Investors Face Sept. 12 Deadline in Securities Class Action